Abstract
Complex diseases are often caused by the function of multiple genes, gene-gene (GxG) interactions as well as gene-environment (GxE) interactions. GxG and GE interactions are ubiquitous in nature. Empirical evidences have shown that the effect of GxG interaction on disease risk could be largely modified by environmental changes. Such a GGE triple interaction could be a potential contributing factor to phenotypic plasticity. Although the role of environmental factors moderating genetic influences on disease risk has been broadly recognized, no statistical method has been developed to rigorously assess how environmental changes modify GxG interactions to affect disease risk. To address this issue, we developed a GxGxE triple interaction model in this work. We modeled the environmental modification effect via a varying-coefficient model where the structure of the varying effect is determined by data. Thus the model has the flexibility to assess nonlinear environmental moderation effect on GxG interaction. Simulation and real data analysis were conducted to show the utility of the method. Our approach provides a quantitative framework to assess triple interactions hypothesized in literature.
Keywords: Associate study, Epistasis, Gene-gene-environment triple interaction, Nonlinear interaction, Varying coefficient model.
Graphical Abstract
Current Genomics
Title:Statistical Identification of Gene-gene Interactions Triggered By Nonlinear Environmental Modulation
Volume: 17 Issue: 5
Author(s): Xu Liu, Honglang Wang and Yuehua Cui
Affiliation:
Keywords: Associate study, Epistasis, Gene-gene-environment triple interaction, Nonlinear interaction, Varying coefficient model.
Abstract: Complex diseases are often caused by the function of multiple genes, gene-gene (GxG) interactions as well as gene-environment (GxE) interactions. GxG and GE interactions are ubiquitous in nature. Empirical evidences have shown that the effect of GxG interaction on disease risk could be largely modified by environmental changes. Such a GGE triple interaction could be a potential contributing factor to phenotypic plasticity. Although the role of environmental factors moderating genetic influences on disease risk has been broadly recognized, no statistical method has been developed to rigorously assess how environmental changes modify GxG interactions to affect disease risk. To address this issue, we developed a GxGxE triple interaction model in this work. We modeled the environmental modification effect via a varying-coefficient model where the structure of the varying effect is determined by data. Thus the model has the flexibility to assess nonlinear environmental moderation effect on GxG interaction. Simulation and real data analysis were conducted to show the utility of the method. Our approach provides a quantitative framework to assess triple interactions hypothesized in literature.
Export Options
About this article
Cite this article as:
Liu Xu, Wang Honglang and Cui Yuehua, Statistical Identification of Gene-gene Interactions Triggered By Nonlinear Environmental Modulation, Current Genomics 2016; 17 (5) . https://dx.doi.org/10.2174/1389202917666160726150417
DOI https://dx.doi.org/10.2174/1389202917666160726150417 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recurrent Hepatitis C After Liver Transplantation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Protein-Tyrosine Phosphatase 1B as a Potential Drug Target for Obesity
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Atopic Dermatitis in the Elderly
Inflammation & Allergy - Drug Targets (Discontinued) Pigment Epithelium-Derived Factor (PEDF): Its Potential Therapeutic Implication in Diabetic Vascular Complications
Current Drug Targets Chemistry and Health Effects of Bioactive Compounds in Selected Culinary Aromatic Herbs
Current Nutrition & Food Science Supercritical Fluid Particle Design for Poorly Water-soluble Drugs (Review)
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Proteomics Clinical Relevance of Postprandial Lipaemia
Current Medicinal Chemistry Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options
Recent Patents on Anti-Cancer Drug Discovery Preface: New Message in 2014 From Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial [Hot Topic: One Century of Triglycerides, but there is Still Lots to Learn(Guest Editors: K. Anagnostopoulou, D.P. Mikhailidis and G. Kolovou)]
Current Drug Targets Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Current Pharmaceutical Design Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery The Quality of Life of Thalassemic Patients: The Role of Endocrine Defect Compensation
Endocrine, Metabolic & Immune Disorders - Drug Targets Cardiovascular Changes in Menopause
Current Cardiology Reviews Evaluation of Self Monitoring of Blood Glucose in Non-Insulin-Treated Diabetic Patients by Randomized Controlled Trials: Little Bang for the Buck
Reviews on Recent Clinical Trials Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
Current Vascular Pharmacology NAD<sup>+</sup>/NADH Metabolism and NAD<sup>+</sup>-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications
Current Medicinal Chemistry Polypharmacology in Precision Oncology: Current Applications and Future Prospects
Current Pharmaceutical Design Mast Cells in Allergic and Inflammatory Diseases
Current Pharmaceutical Design